SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001683168-22-007329
Filing Date
2022-11-07
Accepted
2022-11-07 13:53:47
Documents
1
Period of Report
2022-10-28

Document Format Files

Seq Description Document Type Size
1 ownership.html 3  
1 ownership.xml 3 1521
  Complete submission text file 0001683168-22-007329.txt   2958
Mailing Address 105 BRADFORD ROAD, SUITE 420 WEXFORD PA 15090
Business Address 105 BRADFORD ROAD, SUITE 420 WEXFORD PA 15090 724-934-6467
Coeptis Therapeutics Holdings, Inc. (Issuer) CIK: 0001759186 (see all company filings)

IRS No.: 981465952 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 105 BRADFORD RD., SUITE 420 WEXFORD PA 15090
Business Address
Cochran Christopher P. (Reporting) CIK: 0001951916 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39669 | Film No.: 221364882